Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about BGNE
Recent news which mentions BGNE
< Previous
1
2
3
4
5
6
7
Next >
3 Top Biotech Stocks Defying the Bear Market
April 25, 2023
Tickers
BGNE
BIIB
LLY
NVS
Tags
Market News
LLY
VKTX
From
Motley Fool
BeiGene's Tislelizumab/Chemo Combo Hits Primary Goal In Gastric Cancer Study
April 20, 2023
Tickers
BGNE
Tags
Market News
BGNE
Benzinga
From
Benzinga
7 Biotech Stocks That Could Cure Your Portfolio Woes
April 19, 2023
Tickers
ARGX
BGNE
BMRN
INCY
Tags
ARGX
UTHR
BGNE
From
InvestorPlace
Analysts At H.C. Wainwright & Co. Set 12-Month Target Of $15 Per Share For ENLV Thanks To High Profile Collaboration Agreement, Multiple Ongoing Clinical Trials
April 13, 2023
Tickers
BGNE
BMY
ENLV
MRK
Tags
Enlivex Therapeutics
Partner Content
Biotech
From
Benzinga
Hillstream BioPharma's Drug Candidate HSB-1216 Could Be One To Watch As Global Oncology Market Continues To Grow
April 11, 2023
Tickers
BGNE
BMY
CRMD
DD
Tags
SNY
General
DD
From
Benzinga
Hillstream BioPharma's Drug Candidate HSB-1216 Could Be One To Watch As Global Oncology Market Continues To Grow
April 11, 2023
Tickers
BGNE
BMY
CRMD
DD
Tags
ILMN
Market News
Penny Stocks
From
Benzinga
Enlivex, Beigene Collaborate To Test A New Combination Treatment To Fight Advanced-Stage Solid Tumors
April 11, 2023
Tickers
BGNE
ENLV
Tags
BGNE
Benzinga
Penny Stocks
From
Benzinga
Why BeiGene Stock Jumped Thursday
April 06, 2023
Tickers
BGNE
Tags
Market News
BGNE
Recent Press Releases
From
Motley Fool
Silicon Valley Bank Collapse Might Have Limited Impact On Asia, But Confidence Seems Shaken
March 13, 2023
Tickers
ASIA
BGNE
SIVB
ZLAB
Tags
Health Care
Biotech
ZLAB
From
Benzinga
BeiGene Earnings Perspective: Return On Capital Employed
March 02, 2023
Tickers
BGNE
Tags
BGNE
Benzinga
Earnings
From
Benzinga
Nasdaq, S&P 500 Futures Rebound In New Trading Week But Rising Bond Yields Remain A Risk
February 27, 2023
Tickers
BGNE
FSR
LI
OXY
Tags
Trading Ideas
Futures
SGEN
From
Benzinga
Is Johnson & Johnson Still a Good Dividend Stock to Buy?
January 26, 2023
Tickers
AZN
BGNE
JNJ
Tags
JNJ
Market News
AZN
From
Motley Fool
4 Analysts Have This to Say About BeiGene
January 20, 2023
Tickers
BGNE
Tags
Analyst Ratings
Market News
BGNE
From
Benzinga
Draganfly To Rally Around 87%? Here Are 10 Other Analyst Forecasts For Friday
January 20, 2023
Tickers
BGNE
BILL
DK
DPRO
Tags
JWN
PT Changes
Pre/Market Outlook
From
Benzinga
FDA Approves BeiGene's Brukinsa For Chronic Lymphocytic Leukemia
January 20, 2023
Tickers
BGNE
Tags
Market News
BGNE
Benzinga
From
Benzinga
One of the greatest cancer drugs ever has suddenly lost its edge. This is why it was vulnerable.
January 18, 2023
Tickers
ABBV
AZN
BGNE
JNJ
Tags
ABBV
BGNE
JNJ
From
MarketWatch
U.S.-listed Chinese stocks rise as China eases COVID-19 lockdown restrictions
December 27, 2022
Tickers
BABA
BEKE
BGNE
BIDU
Tags
YUMC
LI
BIDU
From
MarketWatch
Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors
December 27, 2022
Tickers
BGNE
BIIB
CDTX
CHRS
Tags
Top Stories
cancer
XBI
From
Benzinga
Zymeworks Cancer Candidate Shows Objective Response Of 41% In Bile Duct Cancer
December 19, 2022
Tickers
BGNE
ZYME
Tags
Health Care
General
ZYME
From
Benzinga
BeiGene Earnings Perspective: Return On Capital Employed
December 12, 2022
Tickers
BGNE
Tags
BZI/ROCE
Market News
Earnings
From
Benzinga
PayPal To Rally Around 47%? Here Are 10 Other Price Target Changes For Monday
December 12, 2022
Tickers
ACHC
BA
BGNE
CCL
Tags
Analyst Ratings
Market News
PYPL
From
Benzinga
What 5 Analyst Ratings Have To Say About BeiGene
December 12, 2022
Tickers
BGNE
Tags
Analyst Ratings
Market News
BGNE
From
Benzinga
Will Investors Notice Exciting Sign On BeiGene's Chart?
December 06, 2022
Tickers
BGNE
Tags
Trading Ideas
BGNE
Benzinga
From
Benzinga
Why Shares of BeiGene Were Up Wednesday
December 01, 2022
Tickers
BGNE
Tags
Market News
Recent Press Releases
BGNE
From
Motley Fool
Why Leslie's Shares Are Trading Lower By Over 9%? Here Are 60 Stocks Moving In Wednesday's Mid-Day Session
November 30, 2022
Tickers
AGLE
API
ATAT
BBW
Tags
XPEV
NAOV
OTIC
From
Benzinga
Workday, XPeng, Titan Machinery And Some Other Big Stocks Moving Higher On Wednesday
November 30, 2022
Tickers
API
ATAT
AVDL
BBW
Tags
WOOF
News
HZNP
From
Benzinga
Why Horizon Therapeutics Shares Are Trading Higher By Over 30%; Here Are 32 Stocks Moving Premarket
November 30, 2022
Tickers
AKAN
ASPN
BGNE
BXRX
Tags
ASPN
TOUR
Small Cap
From
Benzinga
Quant Ratings Updated on 59 Stocks
November 29, 2022
Tickers
BGNE
BNTX
CZR
FDX
Tags
BNTX
CZR
SNOW
From
InvestorPlace
Dollar Tree, Dycom Industries, Chico's FAS And Other Big Losers From Tuesday
November 23, 2022
Tickers
AGBA
API
ARDX
ATNM
Tags
DLTR
Trading Ideas
ROAD
From
Benzinga
What 4 Analyst Ratings Have To Say About BeiGene
November 10, 2022
Tickers
BGNE
Tags
BZI/AAR
Benzinga
BGNE
From
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.